Weight Loss Injection Prices

Retatrutide Price UK

Learn what Retatrutide may cost in the UK based on early data, and how pricing could compare to Mounjaro and Wegovy.

Whether you have read about retatrutide in news coverage and want to know what it costs in the UK, or are watching its development towards possible approval, this guide explains the current UK price status — which is that no legitimate UK price exists yet — and what's likely to happen when one does. LetsLoseWeight is an independent comparison site; we do not prescribe medication.

Important: Retatrutide is an investigational medicine. As of this guide's last review, it is not licensed by the MHRA and is not available from any regulated UK pharmacy. There is therefore no legitimate UK price for retatrutide at present. Anyone offering retatrutide for sale in the UK outside a registered clinical trial is doing so unlawfully.

Current UK price status: not available, not priced

Retatrutide does not currently have a UK price because it is not currently for sale in the UK through any legitimate channel. The Medicines and Healthcare products Regulatory Agency (MHRA) has not granted marketing authorisation for retatrutide. No GPhC-registered UK pharmacy is supplying it. NICE has not appraised it.

This is the same status as any unapproved prescription medicine in the UK. It is not a regulatory gap, an oversight, or a temporary delay — it is the ordinary process of medicine approval working as designed. New medicines do not enter the UK market until trials, regulatory review and licensing are complete.

When is retatrutide likely to be priced and available?

For retatrutide to have a legitimate UK price, several steps need to happen:

  1. Phase 3 trials complete. The TRIUMPH programme is currently running. Initial readouts have been reported, but full phase 3 data publication and submission for regulatory review is the prerequisite for licensing.

  2. MHRA review and marketing authorisation. Once Eli Lilly submits the data, the MHRA assesses safety, efficacy, manufacturing, and product information. Authorisation typically takes months from submission.

  3. Manufacturer pricing decision. Eli Lilly will set a list price for the UK market. This will reflect manufacturing costs, R&D recovery, market positioning, and competition with existing options.

  4. Distribution to UK pharmacies. Once licensed, retatrutide is supplied through licensed UK wholesalers to GPhC-registered pharmacies, which set their own retail margins.

  5. NICE technology appraisal. Separately, NICE assesses cost-effectiveness for NHS use and decides on funding criteria — typically narrower than the licensed indication.

There is no published timeline. Realistic expectations: probably not in the immediate term. This page will be updated when the situation changes.

What retatrutide is likely to cost when licensed

Drawing comparisons from related medicines and current market positioning:

  • Mounjaro (tirzepatide) — Eli Lilly's existing weight-management medicine, pricing of around £130–£300 per month privately depending on dose
  • Wegovy (semaglutide) — Novo Nordisk's competitor, similar pricing range
  • Retatrutide — same manufacturer as Mounjaro, technically more complex (triple receptor agonism), no biosimilar competition expected for years

A reasonable expectation is that retatrutide private pricing will be in a similar range to Mounjaro, possibly at the higher end. NHS pricing — if NICE recommends NHS funding — will reflect a confidential commercial deal between Eli Lilly and the NHS.

These are forward-looking expectations, not guarantees. Actual pricing will depend on manufacturer strategy, NHS negotiations, market competition, and several other factors not visible at this point.

Why "cheapest" doesn't apply yet

The standard comparison-shopping approach — what's the cheapest provider, what's the discount, what's the bundle pricing — does not work for retatrutide because there is no regulated supply. The cheapest legitimate retatrutide UK price right now is infinity (it cannot be legitimately purchased).

For our reasoning on why "cheapest retatrutide UK" is the wrong question for now, see Cheapest retatrutide UK.

Why prices on unregulated sites should not be compared

Some online sellers, beauty clinics, and social-media sellers are offering retatrutide despite its lack of UK approval. Prices on these sites are not meaningful — not because they are necessarily expensive or cheap, but because:

  • The product has no quality assurance. What's in the vial may not be retatrutide, may be incorrectly dosed, or may be contaminated.
  • The seller has no regulatory accountability. They are operating outside the licensed UK supply chain.
  • The price has no relationship to legitimate market economics. It is whatever the seller chooses to charge.

The MHRA has warned consumers about prescription weight-loss medicines sold without a prescription. The same warning applies — with extra force — to medicines that have not been approved at all.

What you should do instead, if cost matters

If you are considering weight-loss injections and price is an important factor, the legitimate options:

Use a currently licensed alternative

Both Mounjaro and Wegovy are licensed in the UK, well-evidenced, and available at known prices through GPhC-registered pharmacies. See:

Check NHS access first

If you meet the criteria, NHS-funded Mounjaro under TA1026 or Wegovy under TA875 costs only the standard prescription charge — dramatically cheaper than any private route, future or current. See our private vs NHS guide.

Take part in a clinical trial

If retatrutide is the medicine you specifically want, the only legitimate way to access it in the UK at this time is through a registered clinical trial. Trial participation is free and includes proper assessment and safety monitoring. For UK trial sites, see the National Institute for Health and Care Research's Be Part of Research portal.

When this page will change

This page will be updated when retatrutide's UK regulatory status changes. Specifically:

  • When the MHRA grants marketing authorisation, this page will list licensed UK suppliers and current prices
  • When NICE issues a technology appraisal, NHS criteria and funding status will be added
  • When retatrutide is supplied through GPhC-registered pharmacies, this site's price comparison will track provider-by-provider pricing

Until any of those happen, the answer to "what does retatrutide cost in the UK?" is "no legitimate UK price exists yet."

Frequently asked questions

Is there any way to find out what retatrutide will cost when licensed?
Not reliably. Manufacturers do not publish pre-launch pricing. Industry analysts make estimates, but those are speculation. The first reliable pricing will be when the medicine is actually licensed and on sale.

Will retatrutide be cheaper than Mounjaro?
There is no published indication that it will be. Triple agonists are technically more complex than dual agonists, Eli Lilly already has Mounjaro at premium pricing, and there is no obvious commercial reason to undercut it. Equally or more expensive is the more likely outcome at launch.

Can I get retatrutide through a private clinic or aesthetic practice?
A regulated UK clinic associated with a GPhC-registered pharmacy partner cannot supply retatrutide because it is not licensed. A clinic offering retatrutide is operating outside the regulated supply chain — which is the situation the MHRA has specifically warned consumers about.

What if a UK pharmacy says they have retatrutide available?
Verify their GPhC registration and the source of the product. As of this guide's review, no UK pharmacy can legitimately supply retatrutide. A claim that they can is either a misunderstanding of the regulatory position, or an attempt to mislead.

How much weight loss does retatrutide produce in trials, justifying a higher price?
The phase 2 obesity trial reported around 24% average weight loss at the 12mg dose over 48 weeks. This is greater than Mounjaro's published trial average and would be the strongest argument for higher pricing if confirmed in phase 3. See our retatrutide results guide for the full picture and caveats.

Next steps

Sources

This guide is for general information only. Retatrutide is not currently approved or available in the UK outside clinical trials. Anyone offering it for sale in the UK is operating unlawfully.

Get weekly weight loss tips

Join our newsletter for provider updates, expert guidance, and exclusive offers — no spam.

Subscribe free
Back to Prices
Retatrutide Price UK: Why None Exists Yet | LetsLoseWeight